isomethyleugenol has been researched along with Myeloproliferative Disorders in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jutzi, JS; Pahl, HL; Staehle, HF | 1 |
| Chen, FY; Chim, CS; Fung, TK; Zhang, MY | 1 |
| Drexler, HG; Geffers, R; Jost, E; Macleod, RA; Nagel, S; Quentmeier, H; Röhrs, S; Romani, J; Scherr, M; Zaborski, M | 1 |
| Farina, A; Gurvich, N; Hurwitz, J; Menendez, S; Nimer, SD; Perna, F; Voza, F | 1 |
| Ando, K; Kawada, H; Kojima, M; Ogawa, Y; Onizuka, M; Shimada, M; Suzuki, R; Tsuboi, K | 1 |
| Bayar, E; Cortes, J; Faderl, S; Garcia-Manero, G; Giles, FJ; Issa, JP; Kantarjian, HM; Lyons, J; Mannari, R; Rosenfeld, CS; Thomas, D | 1 |
| Bench, AJ; Delabesse, E; Deloukas, P; Fourouclas, N; Green, AR; Hunt, AR; Huntly, BJ; Li, J | 1 |
| Bergo, MO; Fong, LG; Wahlstrom, AM; Young, SG | 1 |
| Ihalainen, J; Juvonen, E; Palotie, A; Ruutu, T; Savolainen, ER | 1 |
| Hara, J; Inoue, M; Ishihara, S; Kawa-Ha, K; Kurahashi, H; Murayama, N; Okada, S; Tawa, A; Yumura-Yagi, K | 1 |
| Chinault, AC; Hardikar, S; Kantarjian, HM; McCredie, KB; Shetta, M; Spitzer, G; Talpaz, M; Taylor, KM | 1 |
| Browett, PJ; Norton, JD | 1 |
2 review(s) available for isomethyleugenol and Myeloproliferative Disorders
| Article | Year |
|---|---|
The Cross Marks the Spot: The Emerging Role of JmjC Domain-Containing Proteins in Myeloid Malignancies.
Topics: Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Methylation; Myelodysplastic Syndromes; Myeloproliferative Disorders | 2021 |
Genetic analyses of the role of RCE1 in RAS membrane association and transformation.
Topics: Animals; Cardiomyopathy, Dilated; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Electrophoresis, Polyacrylamide Gel; Endopeptidases; Fibroblasts; Genes, ras; Hematopoiesis; Humans; Liver; Methylation; Mice; Mice, Knockout; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myeloproliferative Disorders; Protein Processing, Post-Translational; ras Proteins; Transfection | 2008 |
1 trial(s) available for isomethyleugenol and Myeloproliferative Disorders
| Article | Year |
|---|---|
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Cell Cycle Proteins; Cell Differentiation; Child; Child, Preschool; Cohort Studies; Cyclin-Dependent Kinase Inhibitor p15; Decitabine; DNA Methylation; DNA Modification Methylases; Dose-Response Relationship, Drug; Female; Gene Silencing; Hematologic Neoplasms; Humans; Karyotyping; Leukemia; Male; Methylation; Middle Aged; Myeloproliferative Disorders; Time Factors; Treatment Outcome; Tumor Suppressor Proteins | 2004 |
9 other study(ies) available for isomethyleugenol and Myeloproliferative Disorders
| Article | Year |
|---|---|
Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasm.
Topics: Base Sequence; Cell Line, Tumor; DNA Primers; Humans; Methylation; Myeloproliferative Disorders; Philadelphia Chromosome; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Reverse Transcriptase Polymerase Chain Reaction; Suppressor of Cytokine Signaling Proteins | 2013 |
SOCS2: inhibitor of JAK2V617F-mediated signal transduction.
Topics: Apoptosis; Cell Division; Cell Line; Chronic Disease; Cytokines; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Gene Silencing; Humans; Janus Kinase 2; Methylation; Myeloproliferative Disorders; Phosphorylation; Point Mutation; Signal Transduction; STAT5 Transcription Factor; Suppressor of Cytokine Signaling Proteins | 2008 |
L3MBTL1 polycomb protein, a candidate tumor suppressor in del(20q12) myeloid disorders, is essential for genome stability.
Topics: Blotting, Western; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferation; Chromosomal Proteins, Non-Histone; Chromosome Deletion; Chromosomes, Human, Pair 20; DNA Damage; DNA Replication; Genomic Instability; HEK293 Cells; Histones; Humans; Immunoprecipitation; K562 Cells; Lysine; Methylation; Myeloproliferative Disorders; Neoplasm Proteins; Protein Binding; Repressor Proteins; Retinoblastoma Protein; RNA Interference; Tumor Suppressor Proteins | 2010 |
Infrequent hypermethylation of WIF-1 promoter in BCR/ABL-negative myeloproliferative disorders.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Aged, 80 and over; Base Sequence; Chronic Disease; Cohort Studies; CpG Islands; Female; Fusion Proteins, bcr-abl; Humans; Janus Kinase 2; Male; Methylation; Middle Aged; Molecular Sequence Data; Mutation; Myeloproliferative Disorders; Promoter Regions, Genetic; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 2007 |
Characterization of the imprinted polycomb gene L3MBTL, a candidate 20q tumour suppressor gene, in patients with myeloid malignancies.
Topics: Alternative Splicing; Bone Marrow Diseases; Case-Control Studies; Chromosomal Proteins, Non-Histone; Chromosome Deletion; CpG Islands; DNA Mutational Analysis; Gene Expression; Genes, Tumor Suppressor; Humans; Methylation; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasm Proteins; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Sequence Alignment; Tumor Suppressor Proteins | 2004 |
Calcitonin gene methylation in chronic myeloproliferative disorders.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Chronic Disease; DNA; Female; Genes; Humans; Male; Methylation; Middle Aged; Myeloproliferative Disorders; Polycythemia Vera; Primary Myelofibrosis; Thrombocythemia, Essential | 1994 |
Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome.
Topics: Bone Marrow; Cell Differentiation; DNA; Down Syndrome; Female; Genes; Heterozygote; Humans; Hypoxanthine Phosphoribosyltransferase; Infant, Newborn; Infant, Newborn, Diseases; Male; Methylation; Myeloproliferative Disorders; Phosphoglycerate Kinase; Polymorphism, Restriction Fragment Length; Stem Cells; X Chromosome | 1991 |
Myeloproliferative disorders: usefulness of X-linked probes in diagnosis.
Topics: Adult; Blotting, Southern; DNA; DNA Probes; Female; Genetic Linkage; Humans; Hypoxanthine Phosphoribosyltransferase; Leukocytes; Methylation; Middle Aged; Myeloproliferative Disorders; Nucleic Acid Hybridization; Phosphoglycerate Kinase; Polymorphism, Restriction Fragment Length; Predictive Value of Tests; X Chromosome | 1989 |
Analysis of ras gene mutations and methylation state in human leukemias.
Topics: Blotting, Southern; DNA Probes; DNA, Neoplasm; Gene Amplification; Genes, ras; Humans; Leukemia; Methylation; Mutation; Myeloproliferative Disorders; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Restriction Mapping | 1989 |